HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EnviroDerm's IvyBlock

This article was originally published in The Rose Sheet

Executive Summary

Captured 17.4% mass merchandiser dollar share of the poison ivy treatment/prevention category for the 52 weeks ended March 14, according to data from A.C. Nielsen released by EnviroDerm Pharmaceuticals (Louisville, Ky.). Approximately one year after the lotion that prevents poison ivy, oak and sumac rash was introduced in March 1997, IvyBlock generated sales of $1.1 mil. in mass merchandise doors and ranked second in the $6.2 mil. category in that class of trade. Avon Products recently signed a licensing deal with EnviroDerm to market IvyBlock lotion under its Skin-So-Soft label ("The Rose Sheet" April 20, p. 9). Warner-Lambert's Caladryl Clear leads the market, with a 36.7% share and sales of $2.3 mil., while Caladryl was a close third, with a 17.2% share and sales of $1.1 mil. Both Caladryls are treatment products. IvyBlock is the only OTC marketed for prevention...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS005417

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel